News
If anyone UK-based missed out on a stand at Medica and would like a 12 sq m (3mx4m) shell stand on the UK (ABHI) pavilion in Hall 16, please get in touch with Berenice.Mann@clsdiagnostics.com.
Manchester, 9th August, 2023
Kadans Science Partner has submitted a detailed planning application for a state-of-the-art life science building at Upper Brook Street. Working collectively with a consortium of partners, this significant development forms a key part of the transformative vision to deliver an exemplary new neighbourhood for the city.
Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement-mediated diseases, today announced the appointment of Dr Parisa Zamiri as its Chief Medical Officer, effective immediately. Dr. Zamiri brings with her extensive experience in biopharmaceutical and small molecule drug discovery and development, drug and device safety, pharmacovigilance, and biomarker development across various therapeutic areas.
Astex Expands Drug Discovery Collaboration With MSD
Cambridge, UK, 8 August 2023, Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, today announced an exclusive worldwide research collaboration and license agreement with MSD (Merck & Co., Inc., Rahway, N.J., USA). The goal of the collaboration is to identify small molecule candidates with activity towards a tumour suppressor protein for the treatment of cancer.
Dear One Nucleus members,
We are delighted to invite you to Collaborate and Network with your Local Community using Connexn - a new online platform to make team-building easy and intuitive. Created by Cambridge University members and alumni and free to use, Connexn allows easy connection for scientists, entrepreneurs, and creatives in Cambridge and beyond.
Make connections within the area that is right for you and get help with your hands-on project now!
Patients could benefit from bespoke cancer-fighting treatments with fewer side effects thanks to a new partnership between a biotech company and a UK university.
The University of Leicester has joined forces with Cambridge-based Isogenica to develop new immunotherapies – a process where the patient’s immune system is helped to fight cancer – which will be tested on a ‘virtual patient’.
Congratulations to the ten startup companies who celebrated the completion of the Stevenage Bioscience Catalyst's Catalyser Programme.
During the programme, each company were supported by a team of mentors to refine their commercialisation strategies before pictching to an audience of investors, experts and invited guests.
26th edition of the awards recognises the fastest growing technology companies in the UK
Deloitte’s 26th annual Technology Fast 50 awards is open for nominations until 1ST September. The awards rank and recognise the 50 fastest growing technology companies in the UK, based on the last four years of revenue growth. Supporting Deloitte’s initiative for the UK’s fastest growing companies are the award sponsors Oracle NetSuite, BGF and HSBC Innovation Banking.
Huge congratulations to the Cambridge Crystallographic Data Centre (CCDC), the University of Leeds, Tianjin University, and AbbVie Inc. who recently won an Outstanding Manuscript Award from the American Association of Pharmaceutical Scientists (AAPS) for a published research paper in the scientific journal Pharmaceutical Research inves